Samrat Pharmachem Ltd vs Zenlabs Ethica Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Samrat Pharmachem Ltd is ₹ 200.75 as of 12 Jun 15:30 . The P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 17.9 on March 2021 to 76.1 on March 2025 . This represents a CAGR of 33.57% over 5 years The Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 13.77 crore on March 2021 to ₹ 20.32 crore on March 2025 . This represents a CAGR of 8.09% over 5 years The revenue of Samrat Pharmachem Ltd for the Mar '26 is ₹ 71.47 crore as compare to the Dec '25 revenue of ₹ 63.83 crore. This represent the growth of 11.97% The revenue of Zenlabs Ethica Ltd for the Mar '26 is ₹ 10.7 crore as compare to the Dec '25 revenue of ₹ 12.43 crore. This represent the decline of -13.92% The ebitda of Samrat Pharmachem Ltd for the Mar '26 is ₹ -1.55 crore as compare to the Dec '25 ebitda of ₹ -0.26 crore. This represent the growth of 496.15% The ebitda of Zenlabs Ethica Ltd for the Mar '26 is ₹ 0.4 crore as compare to the Dec '25 ebitda of ₹ -1.56 crore. This represent the decline of -125% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -2.04 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Zenlabs Ethica Ltd changed from ₹ 0.04 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 years .

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

About Zenlabs Ethica Ltd

Zenlabs Ethica Limited was initially incorporated in the name of Neelkanth Technologies Limited on 20 July, 1993.
With the due approval from the Registrar of Companies, Ministry of Corporate Affairs, name of the Company was changed to Zenlabs Ethica Limited in 2016-17. The Company is one of the top 10 pharmaceutical contract manufacturing companies in India that develops, markets and exports a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti Hypertensive Drugs, Anti-Infective, Soaps & Anti Bacterial Drugs, Nutraceuticals, etc.
The company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
It offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India. In 2023, the Company ventured into diversified segments like Neurology and Cytrics.

FAQs for the comparison of Samrat Pharmachem Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Samrat Pharmachem Ltd or Zenlabs Ethica Ltd?

Market cap of Samrat Pharmachem Ltd is 62 Cr while Market cap of Zenlabs Ethica Ltd is 23 Cr

What are the key factors driving the stock performance of Samrat Pharmachem Ltd and Zenlabs Ethica Ltd?

The stock performance of Samrat Pharmachem Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Samrat Pharmachem Ltd and Zenlabs Ethica Ltd?

As of June 12, 2026, the Samrat Pharmachem Ltd stock price is INR ₹200.75. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹35.7.

How do dividend payouts of Samrat Pharmachem Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Samrat Pharmachem Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.